C ontrast agents are often used in diagnostic imaging or interventional procedures in clinical radiology or nuclear medicine for the purpose of providing contrast enhancement in images. Additional contrast improves the accuracy of detecting pathologic abnormalities in the underlying biological system or the outcome of the intervention. Some of the contrast agents, however, expose the patient to toxic side effects. Diatrizoate is one of those radiocontrast agents used for imaging kidney and its related structures. It has a high-osmolality and contains iodine for absorption of X-rays and hence for producing localized hyperintensities in computed tomography images. In patients with kidney dysfunction, as measured by serum creatinine clearance level of less than 60 mL/min, diatrizoate may lead to kidney failure (1). This effect is called contrast-induced nephropathy (CIN) and constitutes one of the most common causes of hospital-acquired renal failures in clinical practice. Therefore, it is important to develop preventive and/or protective strategies for safeguarding the kidney to be exposed to diatrizoate.Diatrizoate induces kidney damage through a combination of renal ischemia and direct toxic effect on renal tubular cells (2). The mechanism of pathogenesis includes factors such as impaired nitric oxide production, blockade of vasodilation and generation of reactive oxygen species, all promoting oxidative stress. For preventing kidney from acquiring CIN, past attempts were focused on interventions against toxicity and oxidative stress. In this regard, pharmaceuticals N-acetylcystein (NAC) and calpain inhibitor-1 were investigated and determined to be effective (3). As alternative to such man-made pharmaceuticals, natural compounds found in folk medicine have also gained popularity as viable options in health care. The natural product propolis has been explored on various fronts and its therapeutic